Alfred Chung

Alfred Chung practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Alfred Chung's NPI, 1417375627, was assigned on April 3, 2014. Alfred Chung graduated from Feinberg School of Medicine in 2014. Alfred Chung holds California license A137526.

Alfred Chung's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Alfred Chung's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Alfred Chung to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Alfred Chung practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Alfred Chung's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Alfred Chung is board certified in hematology by the American Board of Internal Medicine. Alfred Chung is licensed in California.

Dmand AI lists anemia, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Alfred Chung treats.

CMS data shows 899 Medicare services from Alfred Chung across 7 procedure codes in 2024, for 240 Medicare patients. Medicare paid $63,508 for them.

CMS counts 240 Medicare patients who saw Alfred Chung in 2024. The largest group is 65 to 74, with 110 patients. 69% of them have high blood pressure, and 68% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Alfred Chung's median patient age at 71, with 41% women.

In 2024, Alfred Chung wrote 553 Medicare Part D claims for 74 patients. 60% of them were for generic drugs. CMS names the drug for 373 of them, across 10 drugs with 11 or more claims each, at $3,928,022 in total drug cost. In 2023, CMS named 350 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Alfred Chung for performance year 2024, reported as part of a group. Alfred Chung accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Alfred Chung as offering telehealth.

Dmand AI links 22 papers to Alfred Chung, published from 2010 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Multiple Myeloma, Receptors, Chimeric Antigen and B-Cell Maturation Antigen. Alfred Chung has published most often in Blood Adv. Alfred Chung's most frequent co-authors are Sandy Wai Kuan Wong, MD, Shagun D. Arora, MD and Nina Shah, MD.

Dmand AI links Alfred Chung to 1 clinical trial. Conditions studied include Multiple Myeloma and Blood Protein Disorders.

CMS Open Payments shows 15 general payments to Alfred Chung from 6 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 96% of the total. Janssen Pharmaceuticals, Inc paid the most, $5,090.

Alfred Chung graduated from Feinberg School of Medicine in 2014.

Alfred Chung is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.